SCHEMBL26043361

SCHEMBL26043361

CS(=O)(=O)Nc1cccc(NC(=O)c2ccc(C(=O)NC3CC3)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.61
▸ DHX9 Q08211 1/20 0.58
▸ MAPK14 Q16539 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ ADRB2 P07550 1/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ RAB9A P51151 2/20 0.51
▸ SMYD3 Q9H7B4 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ NAMPT P43490 1/20 0.50
▸ TYRO3 Q06418 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ ADORA2A P29274 1/20 0.48
▸ ADORA2B P29275 1/20 0.48
▸ ADORA1 P30542 1/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31610082 1.00 HPGD (0.61) HPGDDHX9MAPK14KDM4ETDP1
SCHEMBL27681315 0.82 KCNK3 (0.72) HPGDDHX9KDM4ETDP1SMN1; SMN2
SCHEMBL31610145 0.82 KCNK3 (0.72) HPGDDHX9KDM4ETDP1SMN1; SMN2
SCHEMBL30543903 0.80 HPGD (0.65) HPGDDHX9KDM4ETDP1SMN1; SMN2
SCHEMBL25368211 0.80 HPGD (0.65) HPGDDHX9KDM4ETDP1SMN1; SMN2
SCHEMBL31610059 0.80 HPGD (0.55) HPGDDHX9KDM4ETDP1SMN1; SMN2
SCHEMBL31610066 0.80 HPGD (0.55) HPGDDHX9KDM4ETDP1SMN1; SMN2
SCHEMBL26043564 0.78 EPHX2 (0.59) HPGDDHX9KDM4ETDP1SMN1; SMN2
SCHEMBL26043484 0.77 HPGD (0.61) HPGDDHX9KDM4ETDP1SMN1; SMN2
SCHEMBL27179484 0.77 ADRB2 (0.67) ADRB2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 — — WO disclosed
Send feedback